市場調查報告書

全球糖尿病治療設備市場:2019年∼2025年的預測

Global Diabetes Care Devices Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 920421
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
全球糖尿病治療設備市場:2019年∼2025年的預測 Global Diabetes Care Devices Market 2019-2025
出版日期: 2019年11月12日內容資訊: 英文
簡介

全球糖尿病治療設備市場在預測期間內預計將以6.5%的年複合成長率大幅度成長。全世界的糖尿病的發生率和盛行率的上升,人們對糖尿病的意識高漲,各種糖尿病治療設備的可得性等,為該市場的成長要素。智慧胰島素和人工胰臟等先進產品的出現等糖尿病領域的技術進步,是不久將來該市場成長的機會。但,償付政策的不足和感染的風險,是妨礙市場成長的要素。

本報告提供全球糖尿病治療設備市場的相關調查,市場機會和趨勢,成長及阻礙因素,各產品類型、最終用途、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 報告概要

  • 調查方法、工具
  • 市場分析
    • 各市場區隔
    • 各地區

第2章 市場概要、洞察

  • 報告的範圍
  • 分析師的洞察及目前市場趨勢
    • 主要調查結果
    • 建議
    • 結論
  • 規則與法規

第3章 競爭情形

  • 企業佔有率分析
  • 主要策略分析
  • 主要企業分析
    • Abbott Laboratories Inc.
    • Eli Lilly and Co.
    • B. Braun Melsungen AG
    • Becton Dickinson and Co.
    • Medtronic PLC

第4章 市場決策要素

  • 成長要素
  • 阻礙因素
  • 市場機會

第5章 市場區隔

  • 各產品類型
    • 血糖監測系統設備
    • 胰島素通知設備
  • 各最終用途
    • 醫院
    • 診斷中心
    • 門診病人手術中心(ASC)
    • 居家護理

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他
  • 其他地區

第7章 企業簡介

  • Abbott Laboratories Inc.
  • Arkray, Inc.
  • B. Braun Melsungen AG
  • Bayer Corp.
  • Becton Dickinson and Co.
  • Consort Medical PLC
  • Companion Medical Inc.
  • Dexcom Inc.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche AG
  • Insulet Corp.
  • Medtronic PLC
  • Nova Biomedical, Inc.
  • Novo Nordisk A/S
  • Sanofi SA
  • Sinocare, Inc.
  • Tandem Diabetes Care, Inc.
  • Valeritas Holdings Inc.
  • West Pharmaceutical Services, Inc.
  • Wockhardt Ltd.
  • Ypsomed Holding AG
目錄
Product Code: OMR2020019

The global diabetes care devices market is expected to grow substantially at a CAGR of 6.5% over the forecast period. The growth of the market is backed by various factors including rising incidence and prevalence rate of diabetes across the globe, increasing awareness among the population towards diabetes and availability of a variety of diabetes care devices. However, the dearth of reimbursement policies and risk of infections are the factors that are hindering the market growth. Besides, the technological advancements in the field of diabetes that have led to the emergence of advanced products such as smart insulin and artificial pancreas are promising ample amount of opportunities for market growth in the near future.

The report analyzes the global diabetes care devices market on the basis of product type, end-use, and region. On the basis of product type, the market is sub-segmented into blood glucose monitoring devices and insulin delivery devices. The blood glucose monitoring device segment is further classified into self-monitoring blood glucose meters, continuous glucose monitors, testing strips, and lancets. The blood glucose monitoring devices segment is expected to hold a prominent share in the market. The insulin delivery device segment is further analyzed into insulin pumps, insulin pens, insulin syringes, and insulin jet injectors. Based on the end-use, the market is segmented into hospitals, diagnostic centers, ASCs, and homecare.

Geographically, the market is analyzed into North America, Europe, Asia-Pacific, and the Rest of the World. North America held the dominating position in the global diabetes care devices market in 2018 and is further estimated to follow the same trend over the forecast period. This is due to the high demand for preventive care and early disease diagnosis in nations such as the US and Canada. Apart from this, the rising prevalence of diabetes is further augmenting the need for diabetes care devices in the region. Asia-Pacific is estimated to grow at the fastest growth rate over the forecast period. The growth of the region is backed by the rising geriatric population that is susceptible to diabetes, which is driving the demand for diabetes care devices in the region.

Furthermore, the global diabetes care devices market is influenced by the presence of several players including Abbott Laboratories Inc., Eli Lilly and Co., B. Braun Melsungen AG, Becton Dickinson and Co., Medtronic PLC, Valeritas Holdings Inc., and many others. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players. In February 2019, the US Food and Drug Administration (FDA) announced the approval of Tandem Diabetes Care's t: slim X2 pumps. These pumps can make a reliable and secure communication with digitally connected devices such as insulin dosing software, to receive, execute, and confirm command from these devices.

Research Methodology

The market study of the global diabetes care devices market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for diabetes care devices manufacturers, research organizations, medical device manufacturing companies, hospitals, diagnostic centers, market research firms, government organizations, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. Global Diabetes Care Devices Market Research and Analysis by Product Type

2. Global Diabetes Care Devices Market Research and Analysis by End-Use

The Report covers:

  • Comprehensive research methodology of the global diabetes care devices market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global diabetes care devices market.
  • Insights about market determinants which are stimulating the global diabetes care devices market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Abbott Laboratories Inc.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Eli Lilly and Co.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. B. Braun Melsungen AG
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Becton Dickinson and Co.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Medtronic PLC
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Diabetes Care Devices Market by Product Type
    • 5.1.1. Blood Glucose Monitoring Devices
      • 5.1.1.1. Self-Monitoring Blood Glucose Meters
      • 5.1.1.2. Continuous Glucose Monitors
      • 5.1.1.3. Testing Strips
      • 5.1.1.4. Lancets
    • 5.1.2. Insulin Delivery Devices
      • 5.1.2.1. Insulin Pumps
      • 5.1.2.2. Insulin Pens
      • 5.1.2.3. Insulin Syringes
      • 5.1.2.4. Insulin Jet Injectors
  • 5.2. Global Diabetes Care Devices Market by End-Use
    • 5.2.1. Hospitals
    • 5.2.2. Diagnostic Centers
    • 5.2.3. Ambulatory Surgery Centers (ASCs)
    • 5.2.4. Homecare

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. Japan
    • 6.3.3. India
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories Inc.
  • 7.2. Arkray, Inc.
  • 7.3. B. Braun Melsungen AG
  • 7.4. Bayer Corp.
  • 7.5. Becton Dickinson and Co.
  • 7.6. Consort Medical PLC
  • 7.7. Companion Medical Inc.
  • 7.8. Dexcom Inc.
  • 7.9. Eli Lilly and Co.
  • 7.10. F. Hoffmann-La Roche AG
  • 7.11. Insulet Corp.
  • 7.12. Medtronic PLC
  • 7.13. Nova Biomedical, Inc.
  • 7.14. Novo Nordisk A/S
  • 7.15. Sanofi SA
  • 7.16. Sinocare, Inc.
  • 7.17. Tandem Diabetes Care, Inc.
  • 7.18. Valeritas Holdings Inc.
  • 7.19. West Pharmaceutical Services, Inc.
  • 7.20. Wockhardt Ltd.
  • 7.21. Ypsomed Holding AG

List of Tables

  • 1. GLOBAL DIABETES CARE DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 2. GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL DIABETES CARE DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2018-2025 ($ MILLION)
  • 5. GLOBAL DIABETES CARE DEVICES IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL DIABETES CARE DEVICES IN DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL DIABETES CARE DEVICES IN ASC MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL DIABETES CARE DEVICES IN HOMECARE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL DIABETES CARE DEVICES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 10. NORTH AMERICAN DIABETES CARE DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 11. NORTH AMERICAN DIABETES CARE DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 12. NORTH AMERICAN DIABETES CARE DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2018-2025 ($ MILLION)
  • 13. EUROPEAN DIABETES CARE DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 14. EUROPEAN DIABETES CARE DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 15. EUROPEAN DIABETES CARE DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2018-2025 ($ MILLION)
  • 16. ASIA-PACIFIC DIABETES CARE DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 17. ASIA-PACIFIC DIABETES CARE DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 18. ASIA-PACIFIC DIABETES CARE DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2018-2025 ($ MILLION)
  • 19. REST OF THE WORLD DIABETES CARE DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 20. REST OF THE WORLD DIABETES CARE DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2018-2025 ($ MILLION)

List of Figures

  • 1. GLOBAL DIABETES CARE DEVICES MARKET SHARE BY PRODUCT TYPE, 2018 VS 2025 (%)
  • 2. GLOBAL DIABETES CARE DEVICES MARKET SHARE BY END-USE, 2018 VS 2025 (%)
  • 3. GLOBAL DIABETES CARE DEVICES MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US DIABETES CARE DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA DIABETES CARE DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK DIABETES CARE DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE DIABETES CARE DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY DIABETES CARE DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY DIABETES CARE DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN DIABETES CARE DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. ROE DIABETES CARE DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. CHINA DIABETES CARE DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. JAPAN DIABETES CARE DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. INDIA DIABETES CARE DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD DIABETES CARE DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
Back to Top